Mersana Therapeutics, Inc. (MRSN)
Market: NASD |
Currency: USD
Address: 840 Memorial Drive
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. The company develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen ADC. It has research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana BioSciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.
📈 Mersana Therapeutics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$4.50
-
Upside/Downside from Analyst Target:
1,163.69%
-
Broker Call:
12
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
<0%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Mersana Therapeutics, Inc.
| Date | Reported EPS |
|---|
| 2026-05-13 (estimated upcoming) | - |
| 2026-03-02 (estimated upcoming) | - |
| 2025-11-11 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-08-11 (estimated upcoming) | - |
| 2025-08-10 (estimated upcoming) | - |
| 2025-05-15 | - |
| 2025-05-15 | -0.19 |
| 2025-05-07 | - |
| 2025-05-06 | - |
| 2025-03-03 | -0.11 |
| 2025-02-25 | - |
| 2024-11-13 | -0.09 |
| 2024-08-13 | -0.2 |
| 2024-08-12 | -0.2 |
| 2024-05-09 | -0.16 |
| 2024-05-08 | -0.16 |
| 2024-02-28 | -0.16 |
| 2024-02-27 | -0.16 |
| 2023-11-07 | -0.27 |
| 2023-11-06 | -0.27 |
| 2023-08-08 | -0.47 |
| 2023-08-07 | -0.47 |
| 2023-05-09 | -0.52 |
| 2023-05-08 | -0.52 |
| 2023-02-28 | -0.44 |
| 2023-02-27 | -0.44 |
| 2022-11-07 | -0.61 |
| 2022-11-06 | -0.61 |
| 2022-08-08 | -0.55 |
| 2022-08-07 | -0.55 |
| 2022-05-09 | -0.59 |
| 2022-05-08 | -0.59 |
| 2022-02-28 | -0.68 |
| 2022-02-27 | -0.68 |
| 2021-11-09 | -0.63 |
| 2021-11-08 | -0.63 |
| 2021-08-06 | -0.59 |
| 2021-08-05 | -0.59 |
| 2021-05-10 | -0.5 |
| 2021-05-09 | -0.5 |
| 2021-02-26 | -0.42 |
| 2021-02-25 | -0.42 |
| 2020-11-09 | -0.33 |
| 2020-11-08 | -0.33 |
| 2020-08-07 | -0.33 |
| 2020-08-06 | -0.33 |
| 2020-05-08 | -0.35 |
| 2020-05-07 | -0.35 |
| 2020-02-28 | -0.34 |
| 2020-02-27 | -0.34 |
| 2019-11-05 | -0.35 |
| 2019-08-07 | -0.36 |
| 2019-05-08 | 0.7 |
| 2019-03-07 | -0.97 |
| 2018-11-12 | -0.75 |
| 2018-08-13 | -0.54 |
| 2018-05-13 | -0.54 |
| 2018-03-27 | -0.61 |
| 2017-11-08 | -0.35 |
| 2017-08-10 | -6.33 |
| 2017-06-28 | - |
📰 Related News & Research
No related articles found for "mersana therapeutics".
